» Articles » PMID: 29039776

Roles of Aryl Hydrocarbon Receptor in Aromatase-Dependent Cell Proliferation in Human Osteoblasts

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2017 Oct 18
PMID 29039776
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor and its expression is influenced by environmental compounds, such as 3-methylcholanthrene (3-MC) and β-naphthoflavone (β-NF). AhR and its downstream genes, such as , are considered to play a pivotal role in xenobiotic responses. AhR signaling has also been proposed to mediate osteogenesis in experimental animals, but its details have remained unclear. Therefore, in this study, we examined the possible roles of AhR in human bone. Immunohistochemical analysis revealed that AhR was detected in both osteoblasts and osteoclasts. We then screened AhR-target genes using a microarray analysis in human osteoblastic hFOB cells. Results of microarray and subsequent PCR analysis did reveal that estrogen metabolizing and synthesizing enzymes, such as CYP1B1 and aromatase, were increased by 3-MC in hFOB and osteosarcoma cell line, MG-63. The subsequent antibody cytokine analysis also demonstrated that interleukin-1β and -6 expression was increased by 3-MC and β-NF in hFOB cells and these interleukins were well known to induce aromatase. We then examined the cell proliferation rate of hFOB and MG-63 cells co-treated with 3-MC and testosterone as an aromatase substrate. The status of cell proliferation in both hFOB and MG-63 cells was stimulated by 3-MC and testosterone treatment, which was also inhibited by an estrogen blocker, aromatase inhibitor, or AhR antagonist. These findings indicated that AhR could regulate estrogen synthesis and metabolism in bone tissues through cytokine/aromatase signaling.

Citing Articles

The Utility of Preclinical Models in Understanding the Bone Health of Transgender Individuals Undergoing Gender-Affirming Hormone Therapy.

Venkatesh V, Nie T, Zajac J, Grossmann M, Davey R Curr Osteoporos Rep. 2023; 21(6):825-841.

PMID: 37707757 PMC: 10724092. DOI: 10.1007/s11914-023-00818-2.


Orchiectomy sensitizes cortical bone in male mice to the harmful effects of kynurenine.

Bensreti H, Yu K, Alhamad D, Shaver J, Kaiser H, Zhong R Bone. 2023; 173:116811.

PMID: 37244427 PMC: 10330684. DOI: 10.1016/j.bone.2023.116811.


Endocrine Disruptor-Induced Bone Damage Due to Hormone Dysregulation: A Review.

Iwobi N, Sparks N Int J Mol Sci. 2023; 24(9).

PMID: 37175969 PMC: 10179611. DOI: 10.3390/ijms24098263.


Food Toxicity of Mycotoxin Citrinin and Molecular Mechanisms of Its Potential Toxicity Effects through the Implicated Targets Predicted by Computer-Aided Multidimensional Data Analysis.

Zargar S, Wani T Life (Basel). 2023; 13(4).

PMID: 37109409 PMC: 10142723. DOI: 10.3390/life13040880.


Aryl Hydrocarbon Receptor in Oxidative Stress as a Double Agent and Its Biological and Therapeutic Significance.

Grishanova A, Perepechaeva M Int J Mol Sci. 2022; 23(12).

PMID: 35743162 PMC: 9224361. DOI: 10.3390/ijms23126719.


References
1.
Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T . Expression of estrogen receptor beta in rat bone. Endocrinology. 1997; 138(10):4509-12. DOI: 10.1210/endo.138.10.5575. View

2.
Brauze D, Zawierucha P, Kiwerska K, Bednarek K, Oleszak M, Rydzanicz M . Induction of expression of aryl hydrocarbon receptor-dependent genes in human HepaRG cell line modified by shRNA and treated with β-naphthoflavone. Mol Cell Biochem. 2016; 425(1-2):59-75. PMC: 5225230. DOI: 10.1007/s11010-016-2862-3. View

3.
Izawa T, Arakaki R, Mori H, Tsunematsu T, Kudo Y, Tanaka E . The Nuclear Receptor AhR Controls Bone Homeostasis by Regulating Osteoclast Differentiation via the RANK/c-Fos Signaling Axis. J Immunol. 2016; 197(12):4639-4650. PMC: 5133671. DOI: 10.4049/jimmunol.1600822. View

4.
Miki Y, Hata S, Nagasaki S, Suzuki T, Ito K, Kumamoto H . Steroid and xenobiotic receptor-mediated effects of bisphenol A on human osteoblasts. Life Sci. 2016; 155:29-35. DOI: 10.1016/j.lfs.2016.05.013. View

5.
Kiyama R, Wada-Kiyama Y . Estrogenic endocrine disruptors: Molecular mechanisms of action. Environ Int. 2015; 83:11-40. DOI: 10.1016/j.envint.2015.05.012. View